Inclusion Criteria:  Female patients with melasma. Patients aged 18 years or over and 60 years or less. Patients who agree to participate in the study. -  Exclusion Criteria:  Patients who have other types of facial hyperchromia. Patients who give up, for any reason, to continue treatment. Patients who have any type of allergic reaction to the product.